News Posts List
Phase Ib Trial of SGN-75
08/25/2012
Seattle Genetics, Inc. (SGEN) today announced the initiation of a phase Ib clinical trial evaluating SGN-75 in combination with everolimus (Afinitor®) for patients with advanced metastatic renal cell carcinoma (RCC).
Novel Cancer Marker
08/25/2012
Biosceptre's technology is based on the discovery of what potentially could be the world's first truly universal cancer marker/target â a non-functional cellular receptor (nf-P2X7) that is found on cancer cells but is never present on healthy cells.
Child Cancer Patients at Greater Risk of Diabetes, Study Shows
08/23/2012
Children with kidney cancer were most at risk of developing diabetes, with 14.7 percent of those treated with radiation diagnosed with the condition by age 45, the study found.
How Do Oncologists Sort Through All the New Anticancer Drugs?
08/23/2012
The decades of research into the various molecular mechanistic pathways that cause the constellation of diseases known as âcancerâ have produced literally hundreds of new, exciting experimental medicines.
Supreme Court to Hear Novartis âPatents Versus Patientsâ Case
08/22/2012
Novartis, the Swiss pharmaceutical company, will appear before the Indian Supreme Court Wednesday to appeal against a patent rejection for a popular cancer drug. A decision in favor of the company could have a devastating impact on cheap supplies of many kinds of generic drugs for poor patients.
All Baby Boomers Should Get Tested for Hepatitis C
08/17/2012
New Move Could Identify More Than 800,000 People With Hepatitis C
Pfizer Eyes Kevetrin?
08/14/2012
Cellceutix Corp announced that it has entered into an agreement with Beth Israel Deaconess Medical Center, a teaching hospital of Harvard Medical School, on a research project with Kevetrin.
Blood Test Could Guide Treatment for Kidney Cancer
08/14/2012
Intrigued by those results, the Duke researchers used data from the trial to determine whether a high LDH level was more than just a prognostic tool in advanced kidney cancer, and could perhaps also predict the effectiveness of an mTOR inhibitor.
Grapefruit juice can give cancer drugs dramatic boost
08/12/2012
Researchers from the University of Chicago Medicine said the combination could help patients avoid side effects associated with high doses of the drug and reduce the cost of the medication.
News Feed